Verition Fund Management’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-28,190
Closed -$109K 3329
2024
Q4
$109K Buy
28,190
+11,471
+69% +$63.3K ﹤0.01% 3072
2024
Q3
$123K Buy
+16,719
New +$110K ﹤0.01% 2973
2024
Q2
Sell
-250,191
Closed -$2.63M 2986
2024
Q1
$2.63M Buy
250,191
+191
+0.1% +$1.56K 0.02% 1058
2023
Q4
$2.21M Sell
250,000
-150,000
-38% -$1.15M 0.02% 792
2023
Q3
$3.28M Hold
400,000
0.04% 593
2023
Q2
$4.66M Buy
400,000
+100,000
+33% +$947K 0.06% 387
2023
Q1
$2.31M Buy
+300,000
New +$2.43M 0.03% 654
2019
Q2
Sell
-37,000
Closed -$955K 1060
2019
Q1
$955K Sell
37,000
-23,997
-39% -$664K 0.04% 406
2018
Q4
$1.49M Buy
60,997
+17,997
+42% +$488K 0.11% 178
2018
Q3
$1.24M Buy
43,000
+33,000
+330% +$938K 0.04% 482
2018
Q2
$260K Buy
+10,000
New +$258K 0.02% 915
2017
Q2
Sell
-16,900
Closed -$344K 933
2017
Q1
$344K Buy
+16,900
New +$356K 0.03% 776
2016
Q3
Sell
-11,800
Closed -$140K 1131
2016
Q2
$140K Buy
+11,800
New +$147K 0.02% 807

Other funds holding BAK

Verition Fund Management's BAK Position: Q1 2025 in Review

Verition Fund Management sold out of Braskem (BAK) in Q1 2025, closing a stake of 28,190 shares — an estimated $109K sold.

Verition Fund Management first reported a position in BAK in Q2 2016 and held it in 13 quarters. The position peaked at $4.66M in Q2 2023. 58 funds tracked by Wall St. Rank hold BAK as of Q1 2025.

  • Verition Fund Management reported no remaining Braskem position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 28,190 Braskem shares in Q1 2025, an estimated $109K.
  • Verition Fund Management first reported a position in Braskem in Q2 2016 and held it in 13 quarters.
  • Verition Fund Management's Braskem position peaked at $4.66M in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Braskem as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.